HX-630 (Tohoku University)

N/A

Report date: 2025/01/26 18:10:35
NME

Base Information

Drug NameHX-630 (Tohoku University)
Drug Alias NameHX-630
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor agonists
TargetsRetinoid X receptor
Therapy Area/IndicationsCushing Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTohoku University
China Registration ClassN/A

Develop Information

Active CompaniesTohoku University
Inactive CompaniesN/A
Active IndicationsCushing Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A